Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Atp6v1c1em1/Cya
Common Name:
Atp6v1c1-KO
Product ID:
S-KO-16774
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Atp6v1c1-KO
Strain ID
KOCMP-66335-Atp6v1c1-B6J-VA
Gene Name
Atp6v1c1
Product ID
S-KO-16774
Gene Alias
1700025B18Rik
Background
C57BL/6JCya
NCBI ID
66335
Modification
Conventional knockout
Chromosome
15
Phenotype
MGI:1913585
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Atp6v1c1em1/Cya mice (Catalog S-KO-16774) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022904
NCBI RefSeq
NM_025494
Target Region
Exon 3
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Atp6v1c1, the ATPase H+ transporting V1 subunit C1, is a subunit gene of vacuolar adenosine triphosphatase (V-ATPase). V-ATPase is crucial for proper lumen acidification in many organelles, and its proton-pumping action is involved in various biological processes. It may also be associated with the mTORC1 signaling pathway [1].

In various disease models, Atp6v1c1 has shown significant impacts. In hepatocellular carcinoma (HCC), its high expression in tumor tissues is related to poor prognosis, and knockdown of Atp6v1c1 impairs HCC cell proliferation, migration, and invasion by down-regulating the mTORC1 signaling pathway [1]. In breast cancer cells, depletion of Atp6v1c1 disrupts the normal arrangement of filamentous actin, suggesting its role in breast cancer metastasis [2]. In a mouse model of periodontitis, AAV-mediated Atp6v1c1 knockdown gene therapy can prevent bone erosion and gingival inflammation, reducing osteoclast numbers and inhibiting immune cell infiltration [3]. In esophageal squamous cell carcinoma, suppressing Atp6v1c1 increases the sensitivity of cancer cells to radiotherapy and promotes autophagy [4]. In breast cancer, silencing Atp6v1c1 inhibits lysosomal acidification, impairs cell growth, migration, and invasion, and suppresses tumor growth and metastasis in vivo [5]. In osteoclasts, Atp6v1c1-silencing by lentivirus-mediated RNA interference severely impairs osteoclast acidification activity and bone resorption, and affects F-actin ring formation [6].

In conclusion, Atp6v1c1 is essential for multiple biological processes. Its role in diseases such as cancers (hepatocellular, breast, esophageal squamous cell carcinoma) and periodontitis has been revealed through gene-knockdown and other model-based studies. These findings suggest Atp6v1c1 could be a potential therapeutic target for treating these diseases.

References:

1. Pan, Yuhao, Chen, Hao, Lv, Chenhui, Xu, Yongpeng, Xuan, Qijia. 2024. ATP6V1C1, associated with the tumor microenvironment and mTORC1 signaling pathway, is a potential diagnostic, prognostic, and therapeutic biomarker for hepatocellular carcinoma. In Discover oncology, 15, 673. doi:10.1007/s12672-024-01578-w. https://pubmed.ncbi.nlm.nih.gov/39557733/

2. Cai, Ming, Liu, Pengcheng, Wei, Li, Feng, Shengmei, Deng, Lianfu. 2014. Atp6v1c1 may regulate filament actin arrangement in breast cancer cells. In PloS one, 9, e84833. doi:10.1371/journal.pone.0084833. https://pubmed.ncbi.nlm.nih.gov/24454753/

3. Li, Sheng, Hao, Liang, Wang, Lin, Shao, Jian-Zhong, Chen, Wei. 2015. Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology. In PloS one, 10, e0134903. doi:10.1371/journal.pone.0134903. https://pubmed.ncbi.nlm.nih.gov/26274612/

4. Yao, Xijuan, Chen, Hui, Xu, Bing, Ju, Mengyang, Sun, Xinchen. 2020. The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma. In Gene, 768, 145261. doi:10.1016/j.gene.2020.145261. https://pubmed.ncbi.nlm.nih.gov/33183740/

5. Feng, Shengmei, Zhu, Guochun, McConnell, Matthew, Li, Yi-Ping, Chen, Wei. 2013. Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis. In International journal of biological sciences, 9, 853-62. doi:10.7150/ijbs.6030. https://pubmed.ncbi.nlm.nih.gov/24155661/

6. Feng, Shengmei, Deng, Lianfu, Chen, Wei, Xu, Guoliang, Li, Yi-Ping. . Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts. In The Biochemical journal, 417, 195-203. doi:10.1042/BJ20081073. https://pubmed.ncbi.nlm.nih.gov/18657050/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest